drugset / Trial / NCT02404779

Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents

NCT02404779

Phase 4 Unknown 34 enrolled University Hospital, Clermont-Ferrand
RandomizedParallel-groupOpen-labelTreatment

Summary

Severely brain injured patients are at high risk of intracranial hypertension. Among medical treatments (sedatives), neuromuscular blocking agents (NMBA) are recommended by french but not english speaking societies. Effects of NMBA are unknown. The present study is designed to compare the effects of NMBA versus placebo in the treatment of intracranial hypertension, and the underlying physiopathologic effects.

Timeline

Start
2015-03-19
Primary completion
2022-03-19
Completion
2022-06-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisatracurium Small molecule